Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Insulin pen
by Most Patent Citation in the world in 2022

The Insulin pen top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Citation Insulin pen Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. It was introduced and marketed as NovoPen by the Danish company Novo Nordisk in 1985.
#
Company Name
Region
Tech Topics
Total
1
patent citation: 603
2
DE, US
patent citation: 154
3
Haryana, India
Medical equipment,Health care,Surgical Specialty,
...[+2]
patent citation: 71
4
Dublin, Ireland
patent citation: 71
5
patent citation: 45
6
Basel-Stadt, Switzerland
patent citation: 39
7
Niederösterreich, Austria
patent citation: 36
8
patent citation: 28
9
United Kingdom
Insulin pen,Insulin injection,Health care,
...[+2]
patent citation: 25
10
Hovedstaden, Denmark
Insulin,Health care,Haemophilia,
...[+2]
patent citation: 12
11
Gyeonggi-do, South Korea
patent citation: 8
12
Malta
patent citation: 8
13
patent citation: 6
14
patent citation: 5
15
Electric vehicle,Power grid,Total asset,
...[+2]
patent citation: 4
16
Nordrhein-Westfalen, Germany
Health care,Diabetes Therapy,Immunoprotein,
...[+2]
patent citation: 3
17
patent citation: 3
18
Baden-Wurttemberg, Germany
patent citation: 3
19
patent citation: 3
20
patent citation: 2
Page generation time: Apr 26 2025